A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients

被引：0
|
作者：
Stratta, RJ [1 ]
Taylor, RJ [1 ]
Weide, LG [1 ]
Sindhi, R [1 ]
Sudan, D [1 ]
Castaldo, P [1 ]
Cushing, KA [1 ]
Frisbie, K [1 ]
Radio, SJ [1 ]
机构：
[1] CLARKSON HOSP,OMAHA,NE
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：917 / 918
页数：2
相关论文
共 50 条
  • [1] A randomized prospective trial of OKT3 vs. Basiliximab for induction therapy in renal transplantation.
    Flechner, SM
    Goldfarb, DA
    Fairchild, R
    Cook, D
    Mastroianni, B
    Fisher, R
    Modlin, C
    Gill, I
    Novick, AC
    TRANSPLANTATION, 2000, 69 (08) : S157 - S157
  • [2] OKT3 INDUCTION THERAPY IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    RYCKMAN, FC
    SCHROEDER, TJ
    PEDERSEN, SH
    FISHER, RA
    TCHERVENKOV, JI
    ZIEGLER, M
    FARRELL, M
    HEUBI, J
    BALISTRERI, WF
    HEPATOLOGY, 1990, 12 (04) : 863 - 863
  • [3] QUADRUPLE SEQUENTIAL INDUCTION THERAPY (RX) WITH MALG VS ATGAM VS OKT3 IN RENAL-TRANSPLANTS (TX) PTS - SUPERIORITY OF ATGAM
    BRENNAN, DC
    CERIOTTI, CS
    FLYE, MW
    MILLER, SB
    MILLER, B
    SHENOY, S
    HOWARD, TK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 996 - 996
  • [4] A randomized prospective trial of OKT3 induction in the current immunosuppression era
    Henry, ML
    Pelletier, RP
    Elkhammas, EA
    Bumgardner, GL
    Davies, EA
    Ferguson, RM
    CLINICAL TRANSPLANTATION, 2001, 15 (06) : 410 - 414
  • [5] Induction Immunosuppression in Kidney Transplant Recipients Older than 60 Years of AgeSafety and Efficacy of ATGAM®, OKT3® and Simulect®
    Michael Heifets
    Muhammad I. Saeed
    Mitten H. Parikh
    Debra Sierka
    Mysore S. A. Kumar
    Drugs & Aging, 2004, 21 : 747 - 756
  • [6] Basiliximab vs OKT3 in primary simultaneous pancreas-kidney transplant recipients.
    Elkhammas, EA
    Henry, ML
    Demirag, A
    Carmona, MM
    Bumgardner, GL
    Pelletier, RP
    Ferguson, RM
    TRANSPLANTATION, 2000, 69 (08) : S407 - S407
  • [7] OKT3 INDUCTION IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    BARTOSH, SM
    THISTLETHWAITE, RJ
    ARONSON, AJ
    CLINICAL RESEARCH, 1992, 40 (02): : A388 - A388
  • [8] OKT3 VS ALG INDUCTION THERAPY IN COMBINED PANCREAS-KIDNEY TRANSPLANTATION
    KNECHTLE, SJ
    PIRSCH, JD
    GROSHEK, M
    REED, A
    DALESSANDRO, AM
    KALAYOGLU, M
    BELZER, FO
    SOLLINGER, HW
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1581 - 1582
  • [9] A pilot trial of rhIL-10 in kidney transplant recipients receiving OKT3 induction therapy.
    Wissing, KM
    Morelon, E
    Legendre, C
    Abramowicz, D
    LeBeaut, A
    Grint, P
    Maniscalki, M
    Kreis, H
    Goldman, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3401 - A3401
  • [10] Induction immunosuppression in kidney transplant recipients older than 60 years of age -: Safety and efficacy of ATGAM®, OKT3® and Simulect®
    Heifets, M
    Saeed, MI
    Parikh, MH
    Sierka, D
    Kumar, MSA
    DRUGS & AGING, 2004, 21 (11) : 747 - 756
12345